VIT-MAC1

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameVIT-MAC1
Drug Alias NameVIT-MAC1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVMAC Immunotech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVMAC Immunotech
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell LungPancreatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A